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During the 20th century, biological sciences developed 
enormously and uncovered many mysteries of life. With 
one exception, we have now understood very well the vari-
ous systems of our body, such as the digestive, circulatory 
and reproductive systems. This one exception is the nervous 
system, mainly the brain. The scientific study of the nervous 
system, especially of the brain, has become the hottest field 
in all the biological sciences in the 21st century. This is ev-
idenced by the launch of two giant 10-year, billion-dollar 
projects in 2013—the BRAIN (Brain Research through 
Advancing Innovative Neurotechnologies) Initiative in the 
United States, and the Human Brain Project funded by the 
European Union. China has also spent hundreds of millions 
RMB for brain projects in recent years. If we say that the 
completion of the Human Genome Project was the land-
mark of the last decade, the BRAIN Initiative would be the 
next landmark of biological, or even the natural, sciences. 
A unique feature of brain function, which distinguishes 
the brain from all other organs of our body, is that it gov-
erns our mind and emotions. The brain defines who we are. 
Despite numerous studies in the last decades, little is yet 
known about how the brain works. Our understanding of 
brain function faces special challenges beyond elucidating 
the molecular mechanisms of any other organs and systems 
in an organism. It is likely that we will need to employ a 
whole new theory and/or approach that is completely dif-
ferent from the structural and molecular approaches used for 
dissecting how the other organs/systems of our body work. 
Brain disorders, including neurological and psychiatric 
diseases, pose a huge social, economic and medical burden 
to modern society. For example, Alzheimer’s disease alone 
affects approximately 35 million individuals worldwide at 
present. The prevalence rate would triple and the number of 
patients would quadruple by 2050 if no therapy is found to 
prevent, slow or cure this disease. Can we wait to develop 
therapies for treating brain disorders until we fully under-
stand the disease mechanisms? Unfortunately, we cannot 
afford to wait. Modern research is taking dual approaches 
simultaneously and in parallel to fight brain disorders: basic 
research on brain function, and translational/clinical re-
search with limited knowledge of the fundamental mecha-
nism of the disease. Certainly, these approaches face special 
challenges. 
An effective strategy to meet these special challenges is 
interdisciplinary collaborations among laboratories and in-
stitutions with complementary resources and expertise. In-
ternational collaboration for brain research is a new trend in 
the 21st century. The Joint Laboratory of Neuroscience and 
Cognition (JLNC), which was established in 2010 between 
the Queensland Brain Institute (QBI) at the University of 
Queensland, Australia, and the Institute of Biophysics (IBP) 
at the Chinese Academy of Sciences in Beijing, is a prom-
ising example of such an international collaboration. The 
young joint laboratory has made great achievements within 
a short period of time. This issue of Science China Life Sci-
ences, with the theme of “From brain function to therapy,” 
includes some of the exciting research achievements from 
the JLNC. 
This thematic issue of Science China Life Sciences con-
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sists of six review articles, four research papers, and two 
insights, which cover the major topics of the research col-
laboration at the JLNC, plus one article discussing interna-
tional collaborations on brain and cognitive research. The 
collaborations at the JLNC range from very basic research, 
such as the molecular guidance of axonal sprouting and 
chemical communication among neurons, to a neurodegen-
eration-related molecule called tau that appears to mediate 
neuronal cell death in Alzheimer’s disease and other 
tauopathies.  
The achievements of the JLNC reported in this issue of 
Science China Life Sciences signal the success of the inter-
national collaboration and the fast progress of brain research. 
The extraordinary activity of neuroscience research in Chi-
na is also indicated by the recent publication of a supple-
ment to Science reporting exclusively on studies of neuro-
degeneration and neurodegenerative diseases being con-
ducted in China (Pathways to cures: neurodegenerative dis-
eases in China. S. Sanders, Z. Zhang, B. Tang, Eds. Sci-
ence/AAAS, Washington, DC, 2013). It is predictable that, 
with more successful international collaborations like the 
JLNC and more ambitious efforts by Chinese neuroscien-
tists, neuroscience research in China will likely soon join 
the ranks of international neuroscience pioneers and con-




Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
 
 
 
